MedPath

The effect of frailty on quality of life and lower urinary symptoms after robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL study)

Not Applicable
Conditions
prostate cancer
Registration Number
JPRN-UMIN000040266
Lead Sponsor
Hirosaki University Graduate School of Medicine
Brief Summary

The G8 score and comorbidities have a significant effect on surgical contraindication in patients with localized CaP.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
479
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with prostate cancer treated with radiotherapy or androgen deprivation therapy, and without HRQOL evaluation for 12 months.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of frailty on HRQOL between the frail and nonfrail groups from the baseline to 12 months after RARP.
Secondary Outcome Measures
NameTimeMethod
The effect of frailty on LUTS between the frail and nonfrail groups from the baseline to 12 months after RARP.
© Copyright 2025. All Rights Reserved by MedPath